Local Doctors Hopeful After Promising Pfizer Vaccine News Nov. 10, 2020 A potential COVID-19 vaccine breakthrough after big pharma giant Pfizer said Monday its vaccine is 90 percent effective. "It's incredibly encouraging that the Pfizer vaccine worked," Connick, a professor at the University of Arizona College of Medicine, said. "I think it bodes well for all the vaccines that they may all be successful which will be successful." KVOA-TV (NBC) Tucson
Kids Contract COVID-19 But More Research Needs To Be Done On Possible Long-Term Effects Nov. 10, 2020 Last month, 200,000 children across much of the country were infected with COVID-19, according to a report by the Academy of Pediatrics. While severe illness among kids appears to be rare, researchers don’t know much about the possible long-term effects. Saskia Popescu, an epidemiologist at the University of Arizona's College of Public Health, is interviewed. KJZZ-FM (NPR) Phoenix
Immunotherapy Cancer Vaccine Trial Offers Patients New Hope Nov. 9, 2020 Researchers used a patient’s cancer cells to teach her immune system how to recognize and destroy the cancer, revealing an option for successfully treating others. Read more Thumbnail
UArizona Health Sciences Joint Study Finds Dual Inhibitor Strategy May Be Key to Sustainable COVID-19 Treatment Nov. 9, 2020 Researchers in the College of Pharmacy say compounds targeting proteins involved in viral replication may further drug development for treating COVID-19. Read more Image
Personalized Cancer Vaccine Clinical Trial to Expand Following Promising Early Results Nov. 9, 2020 A study investigating a personalized cancer vaccine has reported a 50% response rate for patients with head and neck cancer in its preliminary data. Read more Image
Pharma Company Licenses UArizona Method for Treating Parkinson's Disease with Ketamine Nov. 9, 2020 In pre-clinical studies, researchers found that low-dose ketamine infusions can improve pain, depression and levodopa-induced dyskinesia in Parkinson's patients. Read more Image
Arizona Sen.-Elect Mark Kelly has Announced His 13-Person Transition Team Nov. 9, 2020 Joe Gerald, an associate professor at the University of Arizona's Mel and Enid Zuckerman College of Public Health and an epidemiologist working on modeling the COVID-19 pandemic, has been named to Arizona Sen.-elect Mark Kelly's 13-person bipartisan transition team. KTAR-FM Phoenix
When Could a Potential Pfizer Vaccine Get to You? Nov. 9, 2020 The trial for the vaccine still needs to be completed. The No. 1 priority is making sure the vaccine is safe, because even a rare side effect could hurt thousands. Dr. Jun Wang, an associate professor in the Department of Pharmacology and Toxicology at the University of Arizona College of Pharmacy said, “We should be excited, but there is way more work to do." KPNX-TV (NBC) Phoenix
Compounds that Inhibit Coronavirus Entry, Replication in Human Cells Identified Nov. 9, 2020 A new study by researchers at the University of South Florida Health Morsani College of Medicine and the University of Arizona College of Pharmacy, offers insight into designing antiviral drugs against COVID-19. Tribune (India)